Keywords: Bayer, Betaferon, Lilly, Cymbalta, Theravance, Astellas, Telavancin

Regulatory approval briefs: Betaferon in China; new use for Lilly’s Cymbalta in USA; update on telavancin

Article | 01 December 2009

Print This

German drug major Bayer Schering Pharma said today that the Chinese State Food and Drug Administration (SFDA) has approved Betaferon ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in